[Classification of chronic graft-versus-host disease]

Area of Science:

• Hematology
• Immunology
• Oncology

Context:

• Allogeneic stem cell transplantation is a curative therapy for hematologic malignancies.
• Chronic graft-versus-host disease (cGVHD) is a major complication affecting long-term survival and quality of life.
• Standardized diagnostic criteria and prognostic models are crucial for managing cGVHD.

Purpose:

• To evaluate the predictive accuracy of the NIH classification for chronic GVHD (cGVHD).
• To identify novel prognostic factors influencing survival in cGVHD patients.
• To refine risk stratification for patients undergoing allogeneic transplantation.

Summary:

• This study analyzed 820 patients receiving allogeneic grafts across three international centers.
• Univariate analysis showed NIH classification, NIH class, and onset type significantly impact survival and mortality.
• Multivariate analysis identified NIH class (HR 2.89) and onset type as independent predictors of survival, with overlap syndrome associated with poorer outcomes.

Impact:

• The NIH class and onset type are confirmed as critical prognostic variables for identifying high-risk patients post-transplantation.
• The study highlights the need for a less laborious classification system, emphasizing organ involvement (lungs, skin, GI, liver) and number of organs affected.
• Findings can guide treatment decisions and improve patient outcomes by better risk stratification in cGVHD.